메뉴 건너뛰기




Volumn 36, Issue 10, 2015, Pages 1763-1769

Linking insulin with Alzheimer’s disease: emergence as type III diabetes

Author keywords

Acetylcholine; Alzheimer s disease; Anti diabetics; Insulin signaling; Tau hyperphosphorylation; Type 3 diabetes

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; AMYLOID BETA PROTEIN; EXENDIN 4; INSULIN; INSULIN RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PLACEBO; ROSIGLITAZONE; TAU PROTEIN;

EID: 84942505240     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-015-2352-5     Document Type: Review
Times cited : (48)

References (74)
  • 1
    • 0035066332 scopus 로고    scopus 로고
    • Alzheimer’s disease: genes, proteins, and therapy
    • COI: 1:CAS:528:DC%2BD3MXislCrsLc%3D, PID: 11274343
    • Selkoe DJ (2001) Alzheimer’s disease: genes, proteins, and therapy. Physiol Rev 81:741–766
    • (2001) Physiol Rev , vol.81 , pp. 741-766
    • Selkoe, D.J.1
  • 2
    • 77953675879 scopus 로고    scopus 로고
    • Probing the biology of Alzheimer’s disease in mice
    • COI: 1:CAS:528:DC%2BC3cXnvFaksLc%3D, PID: 20547123
    • Ashe KH, Zahs KR (2010) Probing the biology of Alzheimer’s disease in mice. Neuron 66:631–645
    • (2010) Neuron , vol.66 , pp. 631-645
    • Ashe, K.H.1    Zahs, K.R.2
  • 3
    • 0037135111 scopus 로고    scopus 로고
    • The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics
    • Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 29:353–356
    • (2002) Science , vol.29 , pp. 353-356
    • Hardy, J.1    Selkoe, D.J.2
  • 4
    • 78650962354 scopus 로고    scopus 로고
    • Insulin levels are decreased in the cerebrospinal fluid of women with prodomal Alzheimers disease
    • COI: 1:CAS:528:DC%2BC3cXhsVektLvL, PID: 20847404
    • Gil-Bea FJ, Solas M, Solomon A, Mugueta C, Winblad B, Kivipelto M et al (2010) Insulin levels are decreased in the cerebrospinal fluid of women with prodomal Alzheimers disease. J Alzheimers Dis 22:405–413
    • (2010) J Alzheimers Dis , vol.22 , pp. 405-413
    • Gil-Bea, F.J.1    Solas, M.2    Solomon, A.3    Mugueta, C.4    Winblad, B.5    Kivipelto, M.6
  • 5
    • 0030915855 scopus 로고    scopus 로고
    • Oxidative stress hypothesis in Alzheimer’s disease
    • COI: 1:CAS:528:DyaK2sXjtlaqs7o%3D, PID: 9165306
    • Markesbery WR (1997) Oxidative stress hypothesis in Alzheimer’s disease. Free Radic Biol Med 23:134–147
    • (1997) Free Radic Biol Med , vol.23 , pp. 134-147
    • Markesbery, W.R.1
  • 6
    • 84872580306 scopus 로고    scopus 로고
    • Insulin and Alzheimer’s disease: untangling the web
    • PID: 22936011
    • Craft S, Cholerton B, Baker LD (2013) Insulin and Alzheimer’s disease: untangling the web. J Alzheimers Dis 33:S263–S275
    • (2013) J Alzheimers Dis , vol.33 , pp. S263-S275
    • Craft, S.1    Cholerton, B.2    Baker, L.D.3
  • 7
    • 15244344784 scopus 로고    scopus 로고
    • Insulin signaling, diabetes mellitus and risk of Alzheimer disease
    • PID: 15750216
    • Zhu X, Perry G, Smith MA (2005) Insulin signaling, diabetes mellitus and risk of Alzheimer disease. J Alzheimers Dis 7:81–84
    • (2005) J Alzheimers Dis , vol.7 , pp. 81-84
    • Zhu, X.1    Perry, G.2    Smith, M.A.3
  • 8
    • 15244350991 scopus 로고    scopus 로고
    • Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer’s disease
    • PID: 15750214
    • de la Monte SM, Wands JR (2005) Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer’s disease. J Alzheimers Dis 7:45–61
    • (2005) J Alzheimers Dis , vol.7 , pp. 45-61
    • de la Monte, S.M.1    Wands, J.R.2
  • 9
    • 15244351255 scopus 로고    scopus 로고
    • Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer’s disease-is this type 3 diabetes?
    • COI: 1:CAS:528:DC%2BD2MXhvVSrtL8%3D, PID: 15750215
    • Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, Tavares R et al (2005) Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer’s disease-is this type 3 diabetes? J Alzheimers Dis 7:63–80
    • (2005) J Alzheimers Dis , vol.7 , pp. 63-80
    • Steen, E.1    Terry, B.M.2    Rivera, E.J.3    Cannon, J.L.4    Neely, T.R.5    Tavares, R.6
  • 10
    • 84863724280 scopus 로고    scopus 로고
    • Alzheimer disease: insulin resistance and AD—extending the translational path
    • COI: 1:CAS:528:DC%2BC38XhtVSgs7zI, PID: 22710630
    • Craft S (2012) Alzheimer disease: insulin resistance and AD—extending the translational path. Nat Rev Neurol 8:360–362
    • (2012) Nat Rev Neurol , vol.8 , pp. 360-362
    • Craft, S.1
  • 11
    • 0019142890 scopus 로고
    • Glycolytic enzymes from human autoptic brain cortex: normal aged and demented cases
    • COI: 1:STN:280:DyaL3M7kslWrsg%3D%3D, PID: 6259457
    • Iwangoff P, Armbruster R, Enz A, Meier-Ruge W (1980) Glycolytic enzymes from human autoptic brain cortex: normal aged and demented cases. Mech Ageing Dev 14:203–209
    • (1980) Mech Ageing Dev , vol.14 , pp. 203-209
    • Iwangoff, P.1    Armbruster, R.2    Enz, A.3    Meier-Ruge, W.4
  • 12
    • 84868094595 scopus 로고    scopus 로고
    • Brain insulin signaling and Alzheimer’s disease: current evidence and future directions
    • PID: 22205300
    • Schiöth HB, Craft S, Brooks SJ, Frey WH II, Benedict C (2012) Brain insulin signaling and Alzheimer’s disease: current evidence and future directions. Mol Neurobiol 46:4–10
    • (2012) Mol Neurobiol , vol.46 , pp. 4-10
    • Schiöth, H.B.1    Craft, S.2    Brooks, S.J.3    Frey, W.H.4    Benedict, C.5
  • 13
    • 0842328001 scopus 로고    scopus 로고
    • Update on adipocyte hormones regulation of energy balance and carbohydrate/lipid metabolism
    • COI: 1:CAS:528:DC%2BD2cXhtlGqtrs%3D, PID: 14749280
    • Havel PJ (2004) Update on adipocyte hormones regulation of energy balance and carbohydrate/lipid metabolism. Diabetes 53:S143–S151
    • (2004) Diabetes , vol.53 , pp. S143-S151
    • Havel, P.J.1
  • 14
    • 0026670206 scopus 로고
    • Insulin in the brain: a hormonal regulator of energy balance
    • COI: 1:CAS:528:DyaK38XmtVGhtbs%3D, PID: 1425482
    • Schwartz MW, Figlewicz DP, Baskin DG, Woods SC, Porte D Jr (1992) Insulin in the brain: a hormonal regulator of energy balance. Endocr Rev 13:387–414
    • (1992) Endocr Rev , vol.13 , pp. 387-414
    • Schwartz, M.W.1    Figlewicz, D.P.2    Baskin, D.G.3    Woods, S.C.4    Porte, D.5
  • 15
    • 0018090354 scopus 로고
    • Insulin receptors are widely distributed in the central nervous system of the rat
    • COI: 1:CAS:528:DyaE1cXkvVCqt7g%3D, PID: 205798
    • Havrankova J, Roth J, Brownstein M (1978) Insulin receptors are widely distributed in the central nervous system of the rat. Nature 272:827–829
    • (1978) Nature , vol.272 , pp. 827-829
    • Havrankova, J.1    Roth, J.2    Brownstein, M.3
  • 16
    • 0014214923 scopus 로고
    • Insulin in the cerebrospinal fluid
    • COI: 1:CAS:528:DyaF2sXltFCju78%3D, PID: 6055448
    • Margolis RU, Altszuler N (1967) Insulin in the cerebrospinal fluid. Nature 215:1375–1376
    • (1967) Nature , vol.215 , pp. 1375-1376
    • Margolis, R.U.1    Altszuler, N.2
  • 17
    • 65649098029 scopus 로고    scopus 로고
    • Phosphorylation of IRS proteins, insulin action, and insulin resistance
    • COI: 1:CAS:528:DC%2BD1MXkvVyhsbY%3D, PID: 18728222
    • Boura-Halfon S, Zick Y (2009) Phosphorylation of IRS proteins, insulin action, and insulin resistance. Am J Physiol Endocrinol Metab 296:E581–E591
    • (2009) Am J Physiol Endocrinol Metab , vol.296 , pp. E581-E591
    • Boura-Halfon, S.1    Zick, Y.2
  • 18
    • 0035947044 scopus 로고    scopus 로고
    • Role of insulin and insulin receptor in learning and memory
    • COI: 1:CAS:528:DC%2BD3MXjslSktLc%3D, PID: 11377828
    • Zhao W-Q, Alkon DL (2001) Role of insulin and insulin receptor in learning and memory. Mol Cell Endocrinol 177:125–134
    • (2001) Mol Cell Endocrinol , vol.177 , pp. 125-134
    • Zhao, W.-Q.1    Alkon, D.L.2
  • 20
    • 42249116015 scopus 로고    scopus 로고
    • Insulin, PKC signaling pathways and synaptic remodeling during memory storage and neuronal repair
    • COI: 1:CAS:528:DC%2BD1cXls1Sjs7s%3D, PID: 18402935
    • Nelson TJ, Sun M-K, Hongpaisan J, Alkon DL (2008) Insulin, PKC signaling pathways and synaptic remodeling during memory storage and neuronal repair. Eur J Pharmacol 585:76–87
    • (2008) Eur J Pharmacol , vol.585 , pp. 76-87
    • Nelson, T.J.1    Sun, M.-K.2    Hongpaisan, J.3    Alkon, D.L.4
  • 22
    • 0001883841 scopus 로고    scopus 로고
    • Molecular mechanisms of brain aging and neurodegenerative disorders: lessons from dietary restriction
    • Prolla TA, Mattson MP (2001) Molecular mechanisms of brain aging and neurodegenerative disorders: lessons from dietary restriction. Trends Neurosci 24:21–31
    • (2001) Trends Neurosci , vol.24 , pp. 21-31
    • Prolla, T.A.1    Mattson, M.P.2
  • 23
    • 12144290448 scopus 로고    scopus 로고
    • Role for neuronal insulin resistance in neurodegenerative diseases
    • COI: 1:CAS:528:DC%2BD2cXitlWht7Y%3D, PID: 14981233
    • Schubert M, Gautam D, Surjo D, Ueki K, Baudler S, Schubert D et al (2004) Role for neuronal insulin resistance in neurodegenerative diseases. Proc Natl Acad Sci USA 101:3100–3105
    • (2004) Proc Natl Acad Sci USA , vol.101 , pp. 3100-3105
    • Schubert, M.1    Gautam, D.2    Surjo, D.3    Ueki, K.4    Baudler, S.5    Schubert, D.6
  • 24
    • 1842734649 scopus 로고    scopus 로고
    • Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimer’s disease
    • COI: 1:CAS:528:DC%2BD2cXjt1Shsbo%3D, PID: 15094077
    • Watson G, Craft S (2004) Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimer’s disease. Eur J Pharmacol 490:97–113
    • (2004) Eur J Pharmacol , vol.490 , pp. 97-113
    • Watson, G.1    Craft, S.2
  • 26
    • 68949089312 scopus 로고    scopus 로고
    • Alzheimer’s disease is type 3 diabetes—evidence reviewed
    • Suzanne M, Wands JR (2008) Alzheimer’s disease is type 3 diabetes—evidence reviewed. J Diabetes Sci Technol 2:1101–1113
    • (2008) J Diabetes Sci Technol , vol.2 , pp. 1101-1113
    • Suzanne, M.1    Wands, J.R.2
  • 27
    • 1842785179 scopus 로고    scopus 로고
    • Glucose metabolism and insulin receptor signal transduction in Alzheimer disease
    • COI: 1:CAS:528:DC%2BD2cXjt1Shsbs%3D, PID: 15094078
    • Hoyer S (2004) Glucose metabolism and insulin receptor signal transduction in Alzheimer disease. Eur J Pharmacol 490:115–125
    • (2004) Eur J Pharmacol , vol.490 , pp. 115-125
    • Hoyer, S.1
  • 28
    • 33845577779 scopus 로고    scopus 로고
    • The role of insulin and neurotrophic factor signaling in brain aging and Alzheimer’s Disease
    • COI: 1:CAS:528:DC%2BD2sXhsFantg%3D%3D, PID: 17049785
    • Cole GM, Frautschy SA (2007) The role of insulin and neurotrophic factor signaling in brain aging and Alzheimer’s Disease. Exp Gerontol 42:10–21
    • (2007) Exp Gerontol , vol.42 , pp. 10-21
    • Cole, G.M.1    Frautschy, S.A.2
  • 29
    • 0029981501 scopus 로고    scopus 로고
    • Cortical synaptic changes and gliosis in normal aging, Alzheimer’s disease and frontal lobe degeneration
    • COI: 1:STN:280:DyaK28zhtFSktg%3D%3D, PID: 8740626
    • Liu X, Erikson C, Brun A (1996) Cortical synaptic changes and gliosis in normal aging, Alzheimer’s disease and frontal lobe degeneration. Dementia 7:128–134
    • (1996) Dementia , vol.7 , pp. 128-134
    • Liu, X.1    Erikson, C.2    Brun, A.3
  • 30
    • 3242739968 scopus 로고    scopus 로고
    • O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer’s disease
    • COI: 1:CAS:528:DC%2BD2cXmtFWmtLs%3D, PID: 15249677
    • Liu F, Iqbal K, Grundke-Iqbal I, Hart GW, Gong C-X (2004) O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer’s disease. Proc Natl Acad Sci USA 101:10804–10809
    • (2004) Proc Natl Acad Sci USA , vol.101 , pp. 10804-10809
    • Liu, F.1    Iqbal, K.2    Grundke-Iqbal, I.3    Hart, G.W.4    Gong, C.-X.5
  • 31
    • 0037221379 scopus 로고    scopus 로고
    • The role of insulin resistance in the pathogenesis of Alzheimer’s disease
    • COI: 1:CAS:528:DC%2BD3sXms1Sjtw%3D%3D, PID: 12467491
    • Watson GS, Craft S (2003) The role of insulin resistance in the pathogenesis of Alzheimer’s disease. CNS Drugs 17:27–45
    • (2003) CNS Drugs , vol.17 , pp. 27-45
    • Watson, G.S.1    Craft, S.2
  • 33
    • 33745402341 scopus 로고    scopus 로고
    • Acetylcholinesterase inhibitors for Alzheimer’s disease: anti-inflammatories in acetylcholine clothing!
    • COI: 1:STN:280:DC%2BD28zntFyhtw%3D%3D, PID: 16788077
    • Tabet N (2006) Acetylcholinesterase inhibitors for Alzheimer’s disease: anti-inflammatories in acetylcholine clothing! Age Ageing 35:336–338
    • (2006) Age Ageing , vol.35 , pp. 336-338
    • Tabet, N.1
  • 34
    • 79251623365 scopus 로고    scopus 로고
    • Diabetes mellitus and Alzheimer’s disease: shared pathology and treatment?
    • COI: 1:CAS:528:DC%2BC3MXjvFSnurk%3D, PID: 21284695
    • Akter K, Lanza EA, Martin SA, Myronyuk N, Rua M, Raffa RB (2011) Diabetes mellitus and Alzheimer’s disease: shared pathology and treatment? Br J Clin Pharmacol 71:365–376
    • (2011) Br J Clin Pharmacol , vol.71 , pp. 365-376
    • Akter, K.1    Lanza, E.A.2    Martin, S.A.3    Myronyuk, N.4    Rua, M.5    Raffa, R.B.6
  • 35
    • 0346731030 scopus 로고    scopus 로고
    • Neuronal thread protein regulation and interaction with microtubule-associated proteins in SH-Sy5y neuronal cells
    • PID: 14685691
    • De la Monte S, Chen G, Rivera E, Wands J (2003) Neuronal thread protein regulation and interaction with microtubule-associated proteins in SH-Sy5y neuronal cells. Cell Mol Life Sci 60:2679–2691
    • (2003) Cell Mol Life Sci , vol.60 , pp. 2679-2691
    • De la Monte, S.1    Chen, G.2    Rivera, E.3    Wands, J.4
  • 36
    • 84859718265 scopus 로고    scopus 로고
    • Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline
    • COI: 1:CAS:528:DC%2BC38Xlt1egtbY%3D, PID: 22476197
    • Talbot K, Wang HY, Kazi H, Han LY, Bakshi KP, Stucky A et al (2012) Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest 122:1316–1338
    • (2012) J Clin Invest , vol.122 , pp. 1316-1338
    • Talbot, K.1    Wang, H.Y.2    Kazi, H.3    Han, L.Y.4    Bakshi, K.P.5    Stucky, A.6
  • 37
    • 33644591150 scopus 로고    scopus 로고
    • Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer’s disease: link to brain reductions in acetylcholine
    • COI: 1:CAS:528:DC%2BD2MXht1ynsLjF, PID: 16340083
    • Rivera EJ, Goldin A, Fulmer N, Tavares R, Wands JR, de la Monte SM (2005) Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer’s disease: link to brain reductions in acetylcholine. J Alzheimers Dis 8:247–268
    • (2005) J Alzheimers Dis , vol.8 , pp. 247-268
    • Rivera, E.J.1    Goldin, A.2    Fulmer, N.3    Tavares, R.4    Wands, J.R.5    de la Monte, S.M.6
  • 38
    • 84890839540 scopus 로고    scopus 로고
    • Antidiabetic drugs and their potential role in treating mild cognitive impairment and Alzheimer’s disease
    • PID: 24333407
    • Alagiakrishnan K, Sankaralingam S, Ghosh M, Mereu L, Senior P (2013) Antidiabetic drugs and their potential role in treating mild cognitive impairment and Alzheimer’s disease. Discov Med 16:277–286
    • (2013) Discov Med , vol.16 , pp. 277-286
    • Alagiakrishnan, K.1    Sankaralingam, S.2    Ghosh, M.3    Mereu, L.4    Senior, P.5
  • 39
    • 79952449386 scopus 로고    scopus 로고
    • Insulin-resistant brain state: the culprit in sporadic Alzheimer’s disease?
    • COI: 1:CAS:528:DC%2BC3MXjtFWjtbw%3D, PID: 21262392
    • Correia SC, Santos RX, Perry G, Zhu X, Moreira PI, Smith MA (2011) Insulin-resistant brain state: the culprit in sporadic Alzheimer’s disease? Ageing Res Rev 10:264–273
    • (2011) Ageing Res Rev , vol.10 , pp. 264-273
    • Correia, S.C.1    Santos, R.X.2    Perry, G.3    Zhu, X.4    Moreira, P.I.5    Smith, M.A.6
  • 40
    • 36448936053 scopus 로고    scopus 로고
    • Common pathological processes in Alzheimer disease and type 2 diabetes: a review
    • COI: 1:CAS:528:DC%2BD2sXhsVSrsr%2FK, PID: 17920690
    • Li L, Hölscher C (2007) Common pathological processes in Alzheimer disease and type 2 diabetes: a review. Brain Res Rev 56:384–402
    • (2007) Brain Res Rev , vol.56 , pp. 384-402
    • Li, L.1    Hölscher, C.2
  • 41
    • 70449732132 scopus 로고    scopus 로고
    • Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer’s disease and diabetes mellitus
    • COI: 1:CAS:528:DC%2BD1MXhsVGms7nP, PID: 19778613
    • Valente T, Gella A, Fernàndez-Busquets X, Unzeta M, Durany N (2010) Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer’s disease and diabetes mellitus. Neurobiol Dis 37:67–76
    • (2010) Neurobiol Dis , vol.37 , pp. 67-76
    • Valente, T.1    Gella, A.2    Fernàndez-Busquets, X.3    Unzeta, M.4    Durany, N.5
  • 42
    • 0037153158 scopus 로고    scopus 로고
    • A central role for JNK in obesity and insulin resistance
    • COI: 1:CAS:528:DC%2BD38XovVekt7g%3D, PID: 12447443
    • Hirosumi J, Tuncman G, Chang L, Görgün CZ, Uysal KT, Maeda K et al (2002) A central role for JNK in obesity and insulin resistance. Nature 420:333–336
    • (2002) Nature , vol.420 , pp. 333-336
    • Hirosumi, J.1    Tuncman, G.2    Chang, L.3    Görgün, C.Z.4    Uysal, K.T.5    Maeda, K.6
  • 43
    • 38049110692 scopus 로고    scopus 로고
    • Amyloid beta oligomers induce impairment of neuronal insulin receptors
    • COI: 1:CAS:528:DC%2BD1cXkslWntw%3D%3D, PID: 17720802
    • Zhao W-Q, De Felice FG, Fernandez S, Chen H, Lambert MP, Quon MJ et al (2008) Amyloid beta oligomers induce impairment of neuronal insulin receptors. FASEB J 22:246–260
    • (2008) FASEB J , vol.22 , pp. 246-260
    • Zhao, W.-Q.1    De Felice, F.G.2    Fernandez, S.3    Chen, H.4    Lambert, M.P.5    Quon, M.J.6
  • 44
    • 67650729973 scopus 로고    scopus 로고
    • β-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin
    • COI: 1:CAS:528:DC%2BD1MXovFegu74%3D, PID: 19605645
    • Ma Q-L, Yang F, Rosario ER, Ubeda OJ, Beech W, Gant DJ et al (2009) β-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin. J Neurosci 29:9078–9089
    • (2009) J Neurosci , vol.29 , pp. 9078-9089
    • Ma, Q.-L.1    Yang, F.2    Rosario, E.R.3    Ubeda, O.J.4    Beech, W.5    Gant, D.J.6
  • 45
    • 84859726053 scopus 로고    scopus 로고
    • An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease–associated Aβ oligomers
    • COI: 1:CAS:528:DC%2BC38Xlt1egtbc%3D, PID: 22476196
    • Bomfim TR, Forny-Germano L, Sathler LB, Brito-Moreira J, Houzel J-C, Decker H et al (2012) An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease–associated Aβ oligomers. J Clin Invest 122:1339–1353
    • (2012) J Clin Invest , vol.122 , pp. 1339-1353
    • Bomfim, T.R.1    Forny-Germano, L.2    Sathler, L.B.3    Brito-Moreira, J.4    Houzel, J.-C.5    Decker, H.6
  • 46
    • 84889656503 scopus 로고    scopus 로고
    • TNF-α mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by Alzheimer’s β-amyloid oligomers in mice and monkeys
    • COI: 1:CAS:528:DC%2BC3sXhvFOlsrnM, PID: 24315369
    • Lourenco MV, Clarke JR, Frozza RL, Bomfim TR, Forny-Germano L, Batista AF et al (2013) TNF-α mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by Alzheimer’s β-amyloid oligomers in mice and monkeys. Cell Metab 18:831–843
    • (2013) Cell Metab , vol.18 , pp. 831-843
    • Lourenco, M.V.1    Clarke, J.R.2    Frozza, R.L.3    Bomfim, T.R.4    Forny-Germano, L.5    Batista, A.F.6
  • 47
    • 60549084867 scopus 로고    scopus 로고
    • Protection of synapses against Alzheimer’s-linked toxins: insulin signaling prevents the pathogenic binding of Aβ oligomers
    • PID: 19188609
    • De Felice FG, Vieira MN, Bomfim TR, Decker H, Velasco PT, Lambert MP et al (2009) Protection of synapses against Alzheimer’s-linked toxins: insulin signaling prevents the pathogenic binding of Aβ oligomers. Proc Natl Acad Sci 106:1971–1976
    • (2009) Proc Natl Acad Sci , vol.106 , pp. 1971-1976
    • De Felice, F.G.1    Vieira, M.N.2    Bomfim, T.R.3    Decker, H.4    Velasco, P.T.5    Lambert, M.P.6
  • 48
    • 34248190279 scopus 로고    scopus 로고
    • Aβ oligomers—a decade of discovery
    • COI: 1:CAS:528:DC%2BD2sXmsFensrc%3D, PID: 17286590
    • Walsh DM, Selkoe DJ (2007) Aβ oligomers—a decade of discovery. J Neurochem 101:1172–1184
    • (2007) J Neurochem , vol.101 , pp. 1172-1184
    • Walsh, D.M.1    Selkoe, D.J.2
  • 49
    • 79959341519 scopus 로고    scopus 로고
    • Cognition and neuropathology in aging: multidimensional perspectives from the Rush Religious Orders Study and Rush Memory and Aging Project
    • COI: 1:CAS:528:DC%2BC3MXosFChsLs%3D, PID: 21222592
    • Negash S, Bennett DA, Wilson RS, Schneider JA, Arnold SE (2011) Cognition and neuropathology in aging: multidimensional perspectives from the Rush Religious Orders Study and Rush Memory and Aging Project. Curr Alzheimer Res 8:336
    • (2011) Curr Alzheimer Res , vol.8 , pp. 336
    • Negash, S.1    Bennett, D.A.2    Wilson, R.S.3    Schneider, J.A.4    Arnold, S.E.5
  • 50
    • 0025987048 scopus 로고
    • Physical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairment
    • COI: 1:STN:280:DyaK387mtFOntw%3D%3D, PID: 1789684
    • Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R et al (1991) Physical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30:572–580
    • (1991) Ann Neurol , vol.30 , pp. 572-580
    • Terry, R.D.1    Masliah, E.2    Salmon, D.P.3    Butters, N.4    DeTeresa, R.5    Hill, R.6
  • 51
    • 11544279355 scopus 로고    scopus 로고
    • Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins
    • COI: 1:STN:280:DyaK1c3mtlektQ%3D%3D, PID: 9600986
    • Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M et al (1998) Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci USA 95:6448–6453
    • (1998) Proc Natl Acad Sci USA , vol.95 , pp. 6448-6453
    • Lambert, M.P.1    Barlow, A.K.2    Chromy, B.A.3    Edwards, C.4    Freed, R.5    Liosatos, M.6
  • 53
    • 0042838303 scopus 로고    scopus 로고
    • Alzheimer’s disease-affected brain: presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss
    • COI: 1:CAS:528:DC%2BD3sXntFyns78%3D, PID: 12925731
    • Gong Y, Chang L, Viola KL, Lacor PN, Lambert MP, Finch CE et al (2003) Alzheimer’s disease-affected brain: presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc Natl Acad Sci 100:10417–10422
    • (2003) Proc Natl Acad Sci , vol.100 , pp. 10417-10422
    • Gong, Y.1    Chang, L.2    Viola, K.L.3    Lacor, P.N.4    Lambert, M.P.5    Finch, C.E.6
  • 54
    • 77954835300 scopus 로고    scopus 로고
    • High-molecular-weight beta-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients
    • COI: 1:CAS:528:DC%2BC3cXhtVeisbbF, PID: 20339023
    • Fukumoto H, Tokuda T, Kasai T, Ishigami N, Hidaka H, Kondo M et al (2010) High-molecular-weight beta-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients. FASEB J 24:2716–2726
    • (2010) FASEB J , vol.24 , pp. 2716-2726
    • Fukumoto, H.1    Tokuda, T.2    Kasai, T.3    Ishigami, N.4    Hidaka, H.5    Kondo, M.6
  • 55
    • 34248547813 scopus 로고    scopus 로고
    • Soluble protein oligomers as emerging toxins in Alzheimer’s and other amyloid diseases
    • COI: 1:CAS:528:DC%2BD2sXlt1Kqsrc%3D, PID: 17505973
    • Ferreira ST, Vieira MN, De Felice FG (2007) Soluble protein oligomers as emerging toxins in Alzheimer’s and other amyloid diseases. IUBMB Life 59:332–345
    • (2007) IUBMB Life , vol.59 , pp. 332-345
    • Ferreira, S.T.1    Vieira, M.N.2    De Felice, F.G.3
  • 56
    • 33847662852 scopus 로고    scopus 로고
    • Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer’s amyloid β-peptide
    • COI: 1:CAS:528:DC%2BD2sXotFKmtw%3D%3D, PID: 17245412
    • Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer’s amyloid β-peptide. Nat Rev Mol Cell Biol 8:101–112
    • (2007) Nat Rev Mol Cell Biol , vol.8 , pp. 101-112
    • Haass, C.1    Selkoe, D.J.2
  • 57
    • 33846633336 scopus 로고    scopus 로고
    • Aβ oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer’s disease
    • COI: 1:CAS:528:DC%2BD2sXhs1Wrsbc%3D, PID: 17251419
    • Lacor PN, Buniel MC, Furlow PW, Clemente AS, Velasco PT, Wood M et al (2007) Aβ oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer’s disease. J Neurosci 27:796–807
    • (2007) J Neurosci , vol.27 , pp. 796-807
    • Lacor, P.N.1    Buniel, M.C.2    Furlow, P.W.3    Clemente, A.S.4    Velasco, P.T.5    Wood, M.6
  • 58
    • 79952797861 scopus 로고    scopus 로고
    • Activation of D1/D5 dopamine receptors protects neurons from synapse dysfunction induced by amyloid-beta oligomers
    • PID: 21115476
    • Jurgensen S, Antonio LL, Mussi GE, Brito-Moreira J, Bomfim TR, De Felice FG et al (2011) Activation of D1/D5 dopamine receptors protects neurons from synapse dysfunction induced by amyloid-beta oligomers. J Biol Chem 286:3270–3276
    • (2011) J Biol Chem , vol.286 , pp. 3270-3276
    • Jurgensen, S.1    Antonio, L.L.2    Mussi, G.E.3    Brito-Moreira, J.4    Bomfim, T.R.5    De Felice, F.G.6
  • 60
    • 34249672242 scopus 로고    scopus 로고
    • Aβ oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine
    • PID: 17308309
    • De Felice FG, Velasco PT, Lambert MP, Viola K, Fernandez SJ, Ferreira ST et al (2007) Aβ oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. J Biol Chem 282:11590–11601
    • (2007) J Biol Chem , vol.282 , pp. 11590-11601
    • De Felice, F.G.1    Velasco, P.T.2    Lambert, M.P.3    Viola, K.4    Fernandez, S.J.5    Ferreira, S.T.6
  • 61
    • 71349085957 scopus 로고    scopus 로고
    • Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer’s disease indicate possible resistance to IGF-1 and insulin signalling
    • COI: 1:CAS:528:DC%2BD1MXhsFGrsL3O, PID: 18479783
    • Moloney AM, Griffin RJ, Timmons S, O’Connor R, Ravid R, O’Neill C (2010) Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer’s disease indicate possible resistance to IGF-1 and insulin signalling. Neurobiol Aging 31:224–243
    • (2010) Neurobiol Aging , vol.31 , pp. 224-243
    • Moloney, A.M.1    Griffin, R.J.2    Timmons, S.3    O’Connor, R.4    Ravid, R.5    O’Neill, C.6
  • 63
    • 33845468713 scopus 로고    scopus 로고
    • Insulin resistance syndrome and Alzheimer disease: pathophysiologic mechanisms and therapeutic implications
    • COI: 1:CAS:528:DC%2BD28Xht1Cnt77P, PID: 17132977
    • Craft S (2006) Insulin resistance syndrome and Alzheimer disease: pathophysiologic mechanisms and therapeutic implications. Alzheimer Dis Assoc Disord 20:298–301
    • (2006) Alzheimer Dis Assoc Disord , vol.20 , pp. 298-301
    • Craft, S.1
  • 64
    • 70349744089 scopus 로고    scopus 로고
    • Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis
    • PID: 19777393
    • de la Monte SM, Longato L, Tong M, Wands JR (2009) Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis. Curr Opin Investig Drugs 10:1049–1060
    • (2009) Curr Opin Investig Drugs , vol.10 , pp. 1049-1060
    • de la Monte, S.M.1    Longato, L.2    Tong, M.3    Wands, J.R.4
  • 65
    • 68949161708 scopus 로고    scopus 로고
    • Mechanisms of nitrosamine-mediated neurodegeneration: potential relevance to sporadic Alzheimer’s disease
    • PID: 19542621
    • de la Monte SM, Tong M (2009) Mechanisms of nitrosamine-mediated neurodegeneration: potential relevance to sporadic Alzheimer’s disease. J Alzheimers Dis 17:817–825
    • (2009) J Alzheimers Dis , vol.17 , pp. 817-825
    • de la Monte, S.M.1    Tong, M.2
  • 66
    • 33645960672 scopus 로고    scopus 로고
    • Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer’s disease
    • COI: 1:CAS:528:DC%2BD28Xjs1Kltb0%3D, PID: 16627931
    • Lester-Coll N, Rivera EJ, Soscia SJ, Doiron K, Wands JR, de la Monte SM (2006) Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer’s disease. J Alzheimers Dis 9:13–33
    • (2006) J Alzheimers Dis , vol.9 , pp. 13-33
    • Lester-Coll, N.1    Rivera, E.J.2    Soscia, S.J.3    Doiron, K.4    Wands, J.R.5    de la Monte, S.M.6
  • 67
    • 0028598190 scopus 로고
    • Intracerebroventricular injection of streptozotocin induces discrete local changes in cerebral glucose utilization in rats
    • COI: 1:CAS:528:DyaK2MXksVOgsrs%3D, PID: 7747600
    • Duelli R, Schröck H, Kuschinsky W, Hoyer S (1994) Intracerebroventricular injection of streptozotocin induces discrete local changes in cerebral glucose utilization in rats. Int J Dev Neurosci 12:737–743
    • (1994) Int J Dev Neurosci , vol.12 , pp. 737-743
    • Duelli, R.1    Schröck, H.2    Kuschinsky, W.3    Hoyer, S.4
  • 68
    • 33748755428 scopus 로고    scopus 로고
    • Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer’s disease
    • PID: 16988486
    • de la Monte SM, Tong M, Lester-Coll N, Plater J, Michael Wands JR (2006) Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer’s disease. J Alzheimers Dis 10:89–109
    • (2006) J Alzheimers Dis , vol.10 , pp. 89-109
    • de la Monte, S.M.1    Tong, M.2    Lester-Coll, N.3    Plater, J.4    Michael, W.J.R.5
  • 69
    • 77953004836 scopus 로고    scopus 로고
    • Early limited nitrosamine exposures exacerbate high fat diet-mediated type 2 diabetes and neurodegeneration
    • PID: 20302640
    • Tong M, Longato L, de la Monte SM (2010) Early limited nitrosamine exposures exacerbate high fat diet-mediated type 2 diabetes and neurodegeneration. BMC Endocr Disord 10:4
    • (2010) BMC Endocr Disord , vol.10 , pp. 4
    • Tong, M.1    Longato, L.2    de la Monte, S.M.3
  • 70
    • 4644286910 scopus 로고    scopus 로고
    • Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer’s disease
    • COI: 1:CAS:528:DC%2BD2cXjvVCltr8%3D, PID: 15033922
    • Ho L, Qin W, Pompl PN, Xiang Z, Wang J, Zhao Z et al (2004) Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer’s disease. FASEB J 18:902–904
    • (2004) FASEB J , vol.18 , pp. 902-904
    • Ho, L.1    Qin, W.2    Pompl, P.N.3    Xiang, Z.4    Wang, J.5    Zhao, Z.6
  • 71
    • 84866357260 scopus 로고    scopus 로고
    • Impaired performance of female APP/PS1 mice in the Morris water maze is coupled with increased Aβ accumulation and microglial activation
    • COI: 1:CAS:528:DC%2BC38Xhtlyqs73O, PID: 22627185
    • Gallagher J, Minogue A, Lynch M (2012) Impaired performance of female APP/PS1 mice in the Morris water maze is coupled with increased Aβ accumulation and microglial activation. Neurodegener Dis 11:33–41
    • (2012) Neurodegener Dis , vol.11 , pp. 33-41
    • Gallagher, J.1    Minogue, A.2    Lynch, M.3
  • 72
    • 27744462921 scopus 로고    scopus 로고
    • Insulin effects on CSF norepinephrine and cognition in Alzheimer’s disease
    • COI: 1:CAS:528:DC%2BD2MXht1egsr3K, PID: 16298239
    • Watson G, Bernhardt T, Reger MA, Cholerton BA, Baker LD, Peskind ER et al (2006) Insulin effects on CSF norepinephrine and cognition in Alzheimer’s disease. Neurobiol Aging 27:38–41
    • (2006) Neurobiol Aging , vol.27 , pp. 38-41
    • Watson, G.1    Bernhardt, T.2    Reger, M.A.3    Cholerton, B.A.4    Baker, L.D.5    Peskind, E.R.6
  • 73
    • 40349091597 scopus 로고    scopus 로고
    • Intranasal insulin improves cognition and modulates β-amyloid in early AD
    • COI: 1:CAS:528:DC%2BD1cXhtFels70%3D, PID: 17942819
    • Reger M, Watson G, Green P, Wilkinson C, Baker L, Cholerton B et al (2008) Intranasal insulin improves cognition and modulates β-amyloid in early AD. Neurology 70:440–448
    • (2008) Neurology , vol.70 , pp. 440-448
    • Reger, M.1    Watson, G.2    Green, P.3    Wilkinson, C.4    Baker, L.5    Cholerton, B.6
  • 74
    • 77950352189 scopus 로고    scopus 로고
    • GLP-1 receptor stimulation reduces amyloid-β peptide accumulation and cytotoxicity in cellular and animal models of Alzheimer’s disease
    • PID: 20308787
    • Li Y, Duffy KB, Ottinger MA, Ray B, Bailey JA, Holloway HW et al (2010) GLP-1 receptor stimulation reduces amyloid-β peptide accumulation and cytotoxicity in cellular and animal models of Alzheimer’s disease. J Alzheimers Dis 19:1205–1219
    • (2010) J Alzheimers Dis , vol.19 , pp. 1205-1219
    • Li, Y.1    Duffy, K.B.2    Ottinger, M.A.3    Ray, B.4    Bailey, J.A.5    Holloway, H.W.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.